STAT

Opinion: Taking a grassroots approach to fighting the opioid epidemic

Doctors and hospitals don't need to wait for large-scale state federal programs to fight inappropriate opioid use.

For many physicians, developing an ongoing relationship with patients is a rewarding part of the job. That’s not the case for emergency physicians like me — we’d rather not see the same patients over and over again, especially those with substance use disorders, who are some of the highest users of emergency care.

I can vividly recall the first time that the opioid epidemic became real to me. One day in September 2011, I was working in the emergency department when a 23-year-old patient arrived in cardiac arrest, apparently caused by an opioid overdose. My team did what it could, but we could not resuscitate the patient. When I talked with his family, they told me that multiple care providers had written him prescriptions for pain medications.

That got me wondering if this tragedy could have been prevented if his providers had been able to easily and securely coordinate

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A J&J Cough Syrup, A Pfizer And Moderna Patent Suit, And More
A Johnson & Johnson children’s cough syrup found to contain unsafe levels of a toxic industrial solvent was sold in six African countries.

Related Books & Audiobooks